Publications by authors named "Johannes Holtschmidt"

Claim this Profile
D
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials.
Fabio Conforti, Johannes Holtschmidt, Valentina Nekljudova, Isabella Sala, Eleonora Pagan

Lancet Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer and HRD-Long-term Survival of the GeparOLA Study.
Peter A Fasching, Sabine Schmatloch, Jan Hauke, Julia Rey, Christian Jackisch, Johannes Holtschmidt

Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of pregnancy on breast cancer immunology: immune biomarker and TIL quantification.
Kristin Galas, Moritz Gleitsmann, Julia Rey, Christine Solbach, Isabell Witzel, Johannes Holtschmidt

NPJ Breast Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer.
Fabio Conforti, Valentina Nekljudova, Isabella Sala, Roberto Ascari, Christine Solbach, Johannes Holtschmidt

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axillary Surgery in Breast Cancer - Primary Results of the INSEMA Trial.
Toralf Reimer, Angrit Stachs, Kristina Veselinovic, Thorsten Kühn, Jörg Heil, Johannes Holtschmidt

N Engl J Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtyping.
Carsten Denkert, Sivaramakrishna Rachakonda, Thomas Karn, Karsten Weber, Miguel Martin, Johannes Holtschmidt

Cancer Cell· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials.
Paul Jank, Thomas Karn, Marion van Mackelenbergh, Judith Lindner, Denise Treue, Johannes Holtschmidt

Clin Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer.
Bruno Valentin Sinn, Katharina Sychra, Michael Untch, Thomas Karn, Marion van Mackelenbergh, Johannes Holtschmidt

Breast Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shifting the Paradigm: The Transformative Role of Neoadjuvant Therapy in Early Breast Cancer.
Nader Hirmas, Johannes Holtschmidt, Sibylle Loibl

Cancers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapy.
David Krug, Valentina Vladimirova, Michael Untch, Thorsten Kühn, Andreas Schneeweiss, Johannes Holtschmidt

Breast· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sacituzumab govitecan in HR+ and HER2- metastatic breast cancer: for all or for some?
Sibylle Loibl, Johannes Holtschmidt

Lancet· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor-Positive/ERBB2-Positive Early Breast Cancer: The Neoadjuvant WSG-TP-II Randomized Clinical Trial.
Oleg Gluz, Ulrike A Nitz, Matthias Christgen, Sherko Kuemmel, Johannes Holtschmidt

JAMA Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients.
Sherko Kuemmel, Joerg Heil, Anna Rueland, Christine Seiberling, Hakima Harrach, Johannes Holtschmidt

Ann Surg· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Reported Use of Radiofrequency Identification (RFID) Technique for Targeted Excision of Suspicious Axillary Lymph Nodes in Early Stage Breast Cancer - Evaluation of Feasibility and Review of Current Recommendations.
Wolfram Malter, Christian Eichler, Bettina Hanstein, Peter Mallmann, Johannes Holtschmidt

In Vivo· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Reported Use of the Faxitron LOCalizer™ Radiofrequency Identification (RFID) System in Europe - A Feasibility Trial, Surgical Guide and Review for Non-palpable Breast Lesions.
Wolfram Malter, Johannes Holtschmidt, Fabinshy Thangarajah, Peter Mallmann, Barbara Krug

In Vivo· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to E. Hindié and A.K. Goel et al.
Johannes Holtschmidt, Sherko Kuemmel, David Krug, Elisabeth Breit, Thorsten Kuehn

J Clin Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial.
Sherko Kuemmel, Johannes Holtschmidt, Bernd Gerber, Albert Von der Assen, Joerg Heil

J Clin Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous Lipotransfer - Daily Therapeutic Practice in Breast Cancer: An Intergroup Analysis Encompassing NOGGO, WSG, GBG, AWO Gyn and DGPRÄC.
Aylin Kümmel, Sherko Kümmel, Jens-Uwe Blohmer, Andree Faridi, Ulrike Nitz, Johannes Holtschmidt

Breast Care (Basel)· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.
Fabinshy Thangarajah, Constanze Vogel, Caroline Pahmeyer, Christian Eichler, Johannes Holtschmidt

Anticancer Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using a New Marker Clip System in Breast Cancer: Tumark Vision® Clip - Feasibility Testing in Everyday Clinical Practice.
Anna Marlene Rüland, Friederike Hagemann, Mattea Reinisch, Johannes Holtschmidt, Aylin Kümmel

Breast Care (Basel)· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematogenous dissemination of glioblastoma multiforme.
Carolin Müller, Johannes Holtschmidt, Martina Auer, Ellen Heitzer, Katrin Lamszus

Sci Transl Med· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis